Cardioprotective effect of thyroid hormone is medi... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice

Full text
Author(s):
da Silva, Ivson Bezerra [1, 2] ; Gomes, Dayane Aparecida [3] ; Alenina, Natalia [4] ; Bader, Michael [4] ; dos Santos, Robson Augusto [5, 6, 7] ; Barreto-Chaves, Maria Luiza M. [1]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Lab Cellular Biol & Funct Anat, Dept Anat, Inst Biomed Sci, Av Prof Lineu Prestes 2415, BR-05508900 Sao Paulo, SP - Brazil
[2] Univ Fed Paraiba, Dept Morphol, Hlth Sci Ctr, Human Anat, Joao Pessoa, Paraiba - Brazil
[3] Fed Univ Pernambuc, Dept Physiol, Biosci Ctr, Recife, PE - Brazil
[4] MaxDelbruck Ctr Mol Med, Berlin - Germany
[5] Univ Fed Minas Gerais, Natl Inst Sci & Technol Nanobiopharmaceut, Belo Horizonte, MG - Brazil
[6] Univ Fed Minas Gerais, Physiol & Biophys Dept, Belo Horizonte, MG - Brazil
[7] Fdn Cardiol, Cardiol Inst Rio Grande do Sul, Porto Alegre, RS - Brazil
Total Affiliations: 7
Document type: Journal article
Source: HEART AND VESSELS; v. 33, n. 6, p. 671-681, JUN 2018.
Web of Science Citations: 2
Abstract

Studies have demonstrated that thyroid hormone (T3) can precondition the heart against ischaemic injury and improve post-ischaemic recovery. This study investigated whether the AT2 receptor (AT2R) is involved in cardioprotection and the potential molecular mechanism responsible for this effect. Hyperthyroidism was induced in male wild-type (WT) and AT2R knockout (KO) mice by administering daily intraperitoneal injections of T3 (7 mu g/100 g body weight) for 14 days. The mouse hearts were harvested and perfused with a Krebs-Henseleit solution at a constant flow in a Langendorff set-up. After 30 min of stabilization, the hearts were subjected to global ischaemia for 20 min and reperfused for 45 min. Baseline cardiac function was assessed by measuring four parameters: LVDP (mmHg), heart rate (bpm), + dP/dt and - dP/dt (mmHg/s). After reperfusion, the total protein from cardiac ventricles was obtained, and the Akt signalling pathway and NO production were evaluated. Post-ischaemic functional recovery was significantly greater (p < 0.05) in the T3-treated WT mice compared to the control, demonstrating the cardioprotective effect of T3. This effect was abolished in T3-treated KO mice, demonstrating the physiological relevance of AT2R to the cardioprotective phenotype induced by T3. Akt activation, iNOS expression and NO production increased in cardiac tissue after T3 treatment in the WT animals, but no difference was observed after treatment in the KO mice. This study indicates that AT2R acts as a cardioprotector in the case of hyperthyroidism. Strategies targeting AT2R agonists might improve cardiac function through NO production and suggest potential therapeutic targets for heart diseases. (AU)

FAPESP's process: 11/12893-4 - Role of Type 2 Angiotensin II Receptor on the cardioprotective effect of Thyroid Hormone in Ischemia/Reperfusion Experimental Model.
Grantee:Ivson Bezerra da Silva
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 13/04703-6 - Subcellular renin angiotensin system as mediator of the cardioprotective effector of thyroid hormone in ischemia reperfusion model
Grantee:Ivson Bezerra da Silva
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)